Author:
Rimmer Y,Chester J,Joffe J,Stark D,Shamash J,Powles T,White J,Wason J,Parashar D,Armstrong G,Mazhar D,Williams M V
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Ardizzoni A, Tjan-Heijnen VCG, Postmus PE (2002) Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European organisation for research and treatment of cancer – lung Cancer Group phase III trial–08923. J Clin Oncol 20: 3947–3955
2. Bissett D, Kunkeler L, Zwanenburg L, Paul J, Gray C, Swan IR, Kerr DJ, Kaye SB (1990) Long-term sequelae of treatment for testicular germ cell tumours. Br J Cancer 62: 655–659
3. Bonilla L, Ben-Aharon I, Vidal L, Gafter-Gvili A, Leibovici L, Stemmer SM (2010) Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst 102: 1845–1854
4. Cancer Therapy Evaluation Program, National Cancer Institute (2006) Common Terminology Criteria for Adverse Events version 3.0 (CTCAE).
http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf
5. Cassidy J, Paul J, Soukop M, Habeshaw T, Reed NS, Parkin D, Kaye SB (1998) Clinical trials of nimodipine as a potential neuroprotector in ovarian cancer patients treated with cisplatin. Cancer Chemother Pharmacol 41: 161–166
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献